Pfizer buying King Pharma for nearly $4 billion

King Pharmaceuticals’ shares rally on all-cash buyout proposed by blue-chip drug maker.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.